Background. There is limited literature evaluating ASP outcomes in patients 65 years and older. The primary objective of this study was to show that ASP efforts to deescalate and/or discontinue antimicrobial therapy in older patients did not lead to an increased rate of 30-day hospital readmissions due to treatment failure. The secondary objective was to show a decrease in antimicrobial expenditure per adjusted patient day (APD).
Background. Intravenous (IV) antibiotics (ABX) are standard for treatment of many inpatient infections. A devastating Puerto Rico hurricane in September 2017 resulted in critical shortages of IV ABX and fluids. In response, a comprehensive review of viable mitigation strategies related to antimicrobials was coordinated at our center to ensure continued excellence in care was provided to all patients.
Methods. A multidisciplinary mitigation task force (MTF) was established to begin immediate fluid conservation efforts from an antimicrobial perspective.
Results. First, ABX regimens were converted to oral equivalents where clinically appropriate. Second, the ABX stewardship team (ASP) offered alternatives to IV ABX that required a large volume of fluid for reconstitution (e.g., ampicillin-sulbactam (A/S, 400 mL fluid/day), meropenem (MER, 300 mL fluid/day). Third, through prospective audit and feedback (PAF), we transitioned patients from A/S (n = 37), cefazolin (n = 21), and IV doxycycline (n = 4) to either oral or alternative IV therapies. We completed additional PAF transitions of IV metronidazole (n = 15) and MER (n = 7). Lastly, 24 ABX products were transitioned to alternative routes of delivery or to diluent fluids. Products were transitioned from mini bags to IV push (n = 10) and IV syringe pump (n = 10). Each product transition required coordinated efforts from over 10 teams including electronic ordering. Education consisted of 20 newsletters created for nursing and 10 order verification packets created for pharmacists. Metrics were established to ensure sustained impact through bi-weekly ABX scorecards. After 6 days of IV metronidazole ASP restriction, use decreased 52% from baseline. With the transitions in place, an average of approximately 100 liters of fluid was conserved per week.
Conclusion. The immediate and collective response of the MTF allowed for the continued capability to provide IV ABX for patient care as supplies fluctuated. Continued education supported safe transitions. Further data will determine the impact of the fluid shortage on patient outcomes once critical supply levels have resolved. These efforts establish a foundation for ongoing initiatives after shortages are resolved.
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Background. Antimicrobials for suspected urinary tract infection (UTI) in advanced cancer patients transitioning to comfort measures (CM) may benefit from stewardship intervention.
Methods. We identified adults ≥65 years with advanced cancer who had ≥1 urine culture obtained during admission to Yale New Haven Hospital from July 2014 to October 2016 that involved transition to CM. We evaluated whether patients met 2017 National Healthcare Safety Network criteria for symptomatic urinary tract infection (UTI). Antimicrobials for suspected UTI and total calendar days of therapy including postdischarge days were evaluated. Factors associated with antimicrobial use were assessed using χ 2 or Fisher's exact testing and fitted in a modified multivariable Poisson regression model.
Results. We identified 327 adults with advanced cancer and ≥1 urine culture obtained during admission involving transition to CM. Median age was 74 years (range, 65-99), 48% (N = 157) were male, and 73% (N = 239) had solid tumors, 21% (N = 70) had liquid tumors, and 6% (N = 18) had unknown primary tumors. Overall, 306 (94%) patients with suspected UTI did not meet criteria for symptomatic UTI. Of these, 14% (N = 43/306) received antimicrobials for suspected UTI resulting in 273 total calendar-days of therapy. Antimicrobial use for suspected UTI was associated with asymptomatic or symptomatic bacteriuria or candiduria (Table 1) . In a multivariable model adjusted for gender, length of stay, liquid tumor, and UTI signs or symptoms, antimicrobial use remained associated with bacteriuria or candiduria (RR = 29.0, 95% CI 11.6, 72.6).
Conclusion. In advanced cancer patients transitioning to CM, inappropriate antimicrobial use for suspected UTI is independently associated with bacteriuria or candiduria but not with UTI signs or symptoms. These findings highlight a potential target for diagnostic (i.e., restricting urine culture orders) and antimicrobial stewardship in this population to promote comfort at the end of life. Disclosures. M. Juthani-Mehta, Iterum Therapeutics: Scientific Advisor, Consulting fee
